Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
+$446M |
| 2 |
NVIDIA
NVDA
|
+$375M |
| 3 |
Apple
AAPL
|
+$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$317M |
| 5 |
Meta Platforms (Facebook)
META
|
+$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
Exxon Mobil
XOM
|
+$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
SoFi Technologies
SOFI
|
+$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Grupo SIMEC
SIM
$3.84B
| $382K | ﹤0.01% |
14,058
-158
| -1% | -$4.29K |
|
3077
J.W. Mays
MAYS
| $379K | ﹤0.01% |
8,620
| – | – |
|
3078
BlackSky Technology
BKSY
$590M
| $378K | ﹤0.01% |
+35,072
| New | +$378K |
|
|
SLRN
3079
DELISTED
ACELYRIN
SLRN
| $371K | ﹤0.01% |
+118,241
| New | +$371K |
|
3080
Zedge
ZDGE
$41.4M
| $365K | ﹤0.01% |
135,624
-4
| -0% | -$11 |
|
|
ACB
3081
Aurora Cannabis
ACB
$272M
| $361K | ﹤0.01% |
84,921
+5,800
| +7% | +$24.7K |
|
3082
Gevo
GEVO
$397M
| $358K | ﹤0.01% |
171,498
+91
| +0.1% | +$190 |
|
3083
NCS Multistage Holdings
NCSM
$115M
| $355K | ﹤0.01% |
13,679
+1,689
| +14% | +$43.8K |
|
3084
AC Immune
ACIU
$221M
| $355K | ﹤0.01% |
131,410
+74,358
| +130% | +$201K |
|
|
JOYY
3085
JOYY Inc. American Depositary Shares
JOYY
$3.27B
| $351K | ﹤0.01% |
8,395
| – | – |
|
3086
Praxis Precision Medicines
PRAX
$858M
| $350K | ﹤0.01% |
4,544
-545
| -11% | -$41.9K |
|
3087
IF Bancorp
IROQ
$82.1M
| $349K | ﹤0.01% |
15,173
+1,320
| +10% | +$30.3K |
|
3088
Melco Resorts & Entertainment
MLCO
$3.75B
| $348K | ﹤0.01% |
60,159
| – | – |
|
3089
Ventyx Biosciences
VTYX
$170M
| $347K | ﹤0.01% |
+158,288
| New | +$347K |
|
3090
Brookfield Asset Management
BAM
$91.8B
| $342K | ﹤0.01% |
6,318
-4,011
| -39% | -$217K |
|
3091
Biohaven
BHVN
$1.68B
| $342K | ﹤0.01% |
9,147
-10
| -0.1% | -$374 |
|
3092
ImmuCell
ICCC
$59.3M
| $341K | ﹤0.01% |
66,306
-6,376
| -9% | -$32.8K |
|
3093
Fossil Group
FOSL
$165M
| $339K | ﹤0.01% |
203,050
+8,286
| +4% | +$13.8K |
|
3094
CKX Lands
CKX
$24M
| $339K | ﹤0.01% |
26,903
| – | – |
|
|
FGNX
3095
Fundamental Global
FGNX
$9.23M
| $338K | ﹤0.01% |
14,527
-3,233
| -18% | -$75.1K |
|
3096
Reading International Class A
RDI
$33.8M
| $337K | ﹤0.01% |
255,291
-54,315
| -18% | -$71.7K |
|
3097
Pathfinder Bancorp
PBHC
$92.5M
| $335K | ﹤0.01% |
19,640
+1,032
| +6% | +$17.6K |
|
3098
Ultragenyx Pharmaceutical
RARE
$3.04B
| $326K | ﹤0.01% |
7,747
-1
| -0% | -$42 |
|
3099
Sera Prognostics
SERA
$121M
| $324K | ﹤0.01% |
39,705
+99
| +0.2% | +$808 |
|
3100
First National Corp
FXNC
$211M
| $323K | ﹤0.01% |
14,041
+2,398
| +21% | +$55.2K |
|